The company informed the Bombay Stock Exchange that it will manufacture this formulation for the US healthcare system from its Piparia (Silvassa) formulations manufacturing.
Total annual market sales for Propranolol Hydrochloride tablets in U.S. were $ 24.1 million in December 2007.
Ipca exports to over 110 countries across the globe. Exports contribute about 50 per cent of the company's income of Rs 1085 crore in the financial year 2007-08.